The Definitive Peptide Research Reference Guide — Compound Review

Dosage Reference

PT-141 Dosage Guide

Complete PT-141 dosage guide covering sexual function protocols, timing, and reconstitution.

Source PT-141 at Purgo Labs Use code HEALTH for 15% off

PT-141 (Bremelanotide) is a melanocortin receptor agonist that activates MC3R and MC4R in the central nervous system to produce sexual arousal. It is FDA-approved as Vyleesi for hypoactive sexual desire disorder in premenopausal women and has robust clinical data in men with erectile dysfunction.

Research Disclaimer: This dosage information is for educational and research purposes only. PT-141 is not FDA-approved for human use (unless otherwise noted). Always consult a qualified healthcare professional before considering any peptide protocol.

PT-141 Dosage Reference

ProtocolDoseNotes
Starting Dose0.5–1mgStart low to assess tolerance. Nausea is the most common side effect at higher doses.
Standard Dose1–2mgMost commonly reported effective dose. 1.75mg is the FDA-approved dose for women.
High Dose2–3mgHigher doses increase efficacy but also nausea risk. Not recommended for new researchers.

Reconstitution

Add 2mL bacteriostatic water to a 10mg vial for a concentration of 5mcg/μL (1mg = 0.2mL = 20 units on a 100-unit syringe).

Timing

Inject 1–2 hours before desired activity. Effects typically onset within 1 hour and last 6–12 hours. Not for daily use — use as needed.

Cycle Length

As-needed use rather than daily cycling. Most researchers limit use to 1–2 times per week maximum.

Storage

Lyophilized powder: refrigerate at 2–8°C. Reconstituted: refrigerate, use within 30 days.

Calculate Your Exact Draw Volume

Use our free peptide calculator to convert your PT-141 dose into exact syringe units based on your vial concentration.

Open Peptide Calculator

Frequently Asked Questions

How long does PT-141 take to work?

Most researchers report onset within 1–2 hours of subQ injection. Effects typically last 6–12 hours.

What is the difference between PT-141 and Melanotan II?

PT-141 is a selective melanocortin agonist optimized for sexual function with a cleaner side effect profile. Melanotan II is less selective and produces tanning alongside sexual effects.

Does PT-141 work for women?

Yes — PT-141 (as Vyleesi) is FDA-approved for hypoactive sexual desire disorder in premenopausal women. It works through a central neurological mechanism that applies to both sexes.

Related Guides

Source Quality PT-141 for Research

Purgo Labs provides pharmaceutical-grade research peptides with third-party COAs. Use code HEALTH for 15% off your first order.

Visit Purgo Labs

Medical Disclaimer: All content on this site is for educational and research purposes only. Research peptides are not FDA-approved for human use. Always consult a qualified healthcare professional before considering any peptide or supplement protocol. Nothing on this site constitutes medical advice, diagnosis, or treatment.

15% OffCode: HEALTH
Shop Purgo Labs